NeurologyLive® Mind Moments®

143 Folgen

1. 128: Machine Learning Algorithms to Predict Seizure Control in Epilepsy Surgery

   Vom: 15.11.2024
2. 127: Adapting Neuromuscular and Electrodiagnostic Medicine Education for Modern Learners

   Vom: 1.11.2024
3. Special Episode: FDA Approves Sodium Oxybate for Pediatric Narcolepsy

   Vom: 23.10.2024
4. 126: Therapeutic Potential of ATH434 in Multiple System Atrophy

   Vom: 18.10.2024
5. 125: Understanding Major Changes to New McDonald Criteria for Multiple Sclerosis

   Vom: 4.10.2024
6. 124: Therapeutic Updates and Progress in Treating Becker Muscular Dystrophy

   Vom: 20.9.2024
7. 123: Previewing Cleveland Clinic's Epilepsy Summit

   Vom: 6.9.2024
8. 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease

   Vom: 23.8.2024
9. 121: Understanding the Potential Cardiovascular Benefits of Low-Sodium Oxybate

   Vom: 9.8.2024
10. 115: Expanding Access to Ublituximab and AntiCD20s for Multiple Sclerosis

    Vom: 31.7.2024
11. 120: Improving Gait in Multiple Sclerosis Through the Neural Sleeve

    Vom: 26.7.2024
12. 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

    Vom: 12.7.2024
13. Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease

    Vom: 9.7.2024
14. 118: Gaining Patient Perspectives on Impact of Narcolepsy

    Vom: 28.6.2024
15. 117: 2024 Consortium of Multiple Sclerosis Centers Annual Meeting Highlights

    Vom: 14.6.2024
16. 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas

    Vom: 31.5.2024
17. 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug Development

    Vom: 3.5.2024
18. Special Episode: FDA Approval of Diazepam Buccal Film for Pediatric Seizures

    Vom: 1.5.2024
19. 113: Lessons Learned in Alzheimer Drug Development

    Vom: 19.4.2024
20. 112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia

    Vom: 5.4.2024